bioRxiv · 10.64898/2026.11.13.766562
High-resolution mapping of the MCT uncovers late blastomere commitment and DREAM/MuvB-mediated restriction of blastomere plasticity
Abstract
Blastomeres are thought to lose multipotency rather sharply during early embryonic development in C. elegans, but the precise timing and regulation of this transition remain incompletely characterised. Here, we present a refined cell-fate challenge assay enabling high-resolution mapping of the multipotency-to-commitment transition (MCT). By combining precise heat-shock timing, 2-cell embryo synchronisation and single nuclei quantification, our method can detect subtle differences in blastomere plasticity across genotypes and developmental stages. Using this approach, we find that the MCT is more gradual than previously appreciated as blastomeres remain competent to adopt the body-wall muscle fate until at least the late 16E stage. We further show that the DREAM/MuvB complex core component LIN-54 restricts blastomere multipotency as does the H3K9 methyltransferase MET-2. Together, our work provides a sensitive single-cell assay for assessing developmental plasticity, reveals an extended timeline for the MCT and suggests that LIN-54/DREAM and MET-2 cooperate to promote blastomere commitment.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Lambert, J., Jarriault, S.. 2026-11-16. High-resolution mapping of the MCT uncovers late blastomere commitment and DREAM/MuvB-mediated restriction of blastomere plasticity. https://doi.org/10.64898/2026.11.13.766562
Cite the original work for its findings. Save a collection to share your selection of sources.